Key result
≥6 B-lines on lung ultrasound is linked to ~4.5-fold higher 30-day mortality in hospitalized HF.
Why the study?
Evidence regarding the association between lung ultrasound B-line burden and short-term mortality specifically in older adults hospitalized with heart failure remains limited.
Does the presence of ≥6 B-lines on lung ultrasound predict 30-day all-cause mortality compared to <6 B-lines in older adults hospitalized with heart failure?
Cohort (n=130)
No
Does the presence of ≥6 B-lines on lung ultrasound predict 30-day all-cause mortality compared to <6 B-lines in older adults hospitalized with heart failure?
Bedside lung ultrasound detection of ≥6 B-lines is strongly associated with a more than four-fold increased risk of 30-day mortality in older adults hospitalized with heart failure.
Answers are grounded in this paper and cite their sources.
May aid prognostication in older HF inpatients; leaves open whether B-line-guided therapy improves outcomes.
Background Lung ultrasound enables bedside assessment of pulmonary congestion through B-line quantification. However, evidence regarding the association between B-line burden and short-term mortality specifically in older adults hospitalized with heart failure remains limited. Objective To evaluate the association between the presence of six or more B-lines on lung ultrasound and 30-day all-cause mortality in older adults hospitalized with heart failure. Methods An observational, analytical, prospective cohort study was conducted at a secondary-care hospital in Torreón, Mexico. A total of 130 older adults hospitalized with heart failure underwent bedside lung ultrasound using an eight-zone protocol. Patients were classified according to the presence of <6 or ≥6 B-lines and followed for 30 days. Demographic and clinical characteristics were compared between groups, and the association with mortality was estimated using the unadjusted relative risk (RR) with a 95% confidence interval (CI). An exploratory sensitivity analysis was performed using modified Poisson regression with robust standard errors, adjusting for age, sex, and chronic kidney disease. Results Of the 130 participants, 74 (56.9%) had ≥6 B-lines and 56 (43.1%) had <6 B-lines. Overall, 28 patients (21.5%) died within 30 days. Mortality occurred in 24/74 (32.4%) patients with ≥6 B-lines compared with 4/56 (7.1%) patients with <6 B-lines (χ² = 12.06; p < 0.001), corresponding to an unadjusted RR of 4.54 (95% CI: 1.67-12.34). In the exploratory analysis of 127 patients, the association persisted after adjustment for age, sex, and chronic kidney disease (adjusted RR = 4.20; 95% CI: 1.54-11.42; p = 0.005). B-type natriuretic peptide (BNP) concentrations were higher in the ≥6 B-line group than in the <6 B-line group (median (q25-q75): 8815 (3000-35000) versus 297 (122-533.75) pg/mL; n = 37 and n = 50, respectively; U = 132.5; p < 0.001). Chronic kidney disease was also more frequent in the ≥6 B-line group (18/73 (24.7%) vs. 2/54 (3.7%); χ² = 10.27; p = 0.001). Conclusions The presence of ≥6 B-lines on lung ultrasound was associated with higher 30-day all-cause mortality among older adults hospitalized with heart failure. This association persisted after exploratory adjustment for age, sex, and chronic kidney disease. These findings suggest that B-line quantification may provide complementary information for short-term risk assessment, although larger studies with more comprehensive adjustment are needed to establish its independent prognostic value.
No takes yet. Share an insight, caveat, or question.
Barraza-Rangel et al. (2026) conducted a cohort in Heart failure (n=130). ≥6 B-lines on lung ultrasound vs. <6 B-lines on lung ultrasound was evaluated on 30-day all-cause mortality (RR 4.54, 95% CI 1.67-12.34, p=<0.001). Having ≥6 B-lines on lung ultrasound was associated with higher 30-day mortality vs <6 B-lines in older hospitalized HF patients.
Synapse has enriched 10 related papers. Consider them for comparative context: